セルライト治療世界市場 2023-2030

GLOBAL CELLULITE TREATMENT MARKET 2023-2030

市場の展望 Tritonの調査レポートは、世界のセルライト治療市場が予測期間2023-2030年にCAGR 9.48%で成長すると予測しています。消費者の美意識の高まりにより、美容施術の需要が大幅に増加しています。侵襲的... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Triton Market Research トリトンマーケットリサーチ	2023年5月2日	US$2,750 シングルユーザライセンスライセンス・価格情報注文方法はこちら	199	英語

目次
図表リスト

サマリー

市場の展望
Tritonの調査レポートは、世界のセルライト治療市場が予測期間2023-2030年にCAGR 9.48%で成長すると予測しています。
消費者の美意識の高まりにより、美容施術の需要が大幅に増加しています。侵襲的な施術に比べ、傷跡が残りにくく、回復期間が短く、合併症が少ないことから、低侵襲な施術への需要が急増しています。非侵襲的・低侵襲的な美容施術の利点に関する認識が高まるにつれ、セルライト治療市場は拡大すると予測されます。
技術の進歩や顧客ニーズの変化に伴い、進歩や革新のために製品の発売が必要になっています。しかし、こうした技術革新は必要である一方、最終消費者の価格上昇につながることも多く、ひいては市場成長の妨げとなる可能性があります。

地域別展望
世界規模のセルライト治療市場は、アジア太平洋、北米、中南米、欧州、中東・アフリカなど、広大な地域をカバーしています。
アジア太平洋地域は、予測期間中、世界的に最も速い成長を遂げると予測されています。この成長は、同地域に熟練した専門家と高品質の医療施設が豊富にあることに起因しています。さらに、この地域の医療観光産業は、プレミアムな医療サービスの利用や治療費の安さから盛んになっており、セルライト治療市場全体の発展に拍車をかけています。

競争展望
セルライト治療市場の著名企業には、Candela Medical Corporation、Galderma SA、AbbVie Inc、Endo International Plc、Inceler Medikal、Johnson & Johnson、Bausch Health Companies Inc、Sientra Inc、Cutera Inc、およびZimmer MedizinSysteme GmbHがあります。

Bausch Health Companies Incは、神経学、皮膚科学、消化器学、国際的な医薬品を中心に、多様な製品の開発、製造、マーケティングに特化しています。本社はカナダにあり、北米、中東・アフリカ、ヨーロッパ、アジア太平洋、中南米で事業を展開しています。製品のひとつであるVaserlipoは、超音波エネルギーを利用した低侵襲のボディコンティングソリューションである。

ページTOPに戻る

TABLE OF CONTENTS
1. GLOBAL CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. PARENT MARKET ANALYSIS
2.2. IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1. COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2. UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET MATURITY ANALYSIS
2.5. INDUSTRY COMPONENTS
2.5.1. RESEARCH AND DEVELOPMENT
2.5.2. MANUFACTURING OF PRODUCT
2.5.3. DISTRIBUTION
2.5.4. POST-SALES MONITORING
2.6. REGULATORY FRAMEWORK
2.7. KEY BUYING IMPACT ANALYSIS
2.7.1. PRICE
2.7.2. BRAND NAME
2.7.3. USABILITY
2.8. KEY MARKET STRATEGIES
2.8.1. COLLABORATIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. MERGERS & ACQUISITIONS
2.8.4. BUSINESS DIVESTITURES & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. GROWING PREVALENCE OF OBESITY
2.9.2. RAPIDLY GROWING MEDICAL TOURISM SECTOR
2.9.3. RISING DEMAND FOR AESTHETIC PROCEDURES
2.10. MARKET CHALLENGES
2.10.1. LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2. HIGH PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3. RISKS ASSOCIATED POST-TREATMENT
2.11. MARKET OPPORTUNITIES
2.11.1. RISING BEAUTY CONSCIOUSNESS
2.11.2. INCREASING TREND OF ANTI-CELLULITE MASSAGE
2.11.3. GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4. RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5. ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12. ANALYST PERSPECTIVE
3. GLOBAL CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1. SOFT CELLULITE
3.2. HARD CELLULITE
3.3. EDEMATOUS CELLULITE
4. GLOBAL CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1. NON-INVASIVE
4.2. MINIMALLY INVASIVE
4.3. TOPICAL
5. GLOBAL CELLULITE TREATMENT MARKET – BY END-USER
5.1. HOSPITALS
5.2. CLINICS AND BEAUTY CENTERS
5.3. OTHER END-USERS
6. GLOBAL CELLULITE TREATMENT MARKET – BY REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET BY CELLULITE TYPE
6.1.2. MARKET BY PROCEDURE TYPE
6.1.3. MARKET BY END-USER
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.1.1. UNITED STATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.4.2. CANADA
6.1.4.2.1. CANADA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2. EUROPE
6.2.1. MARKET BY CELLULITE TYPE
6.2.2. MARKET BY PROCEDURE TYPE
6.2.3. MARKET BY END-USER
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.1.1. UNITED KINGDOM CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.2. GERMANY
6.2.4.2.1. GERMANY CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.3. FRANCE
6.2.4.3.1. FRANCE CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.4. ITALY
6.2.4.4.1. ITALY CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.5. SPAIN
6.2.4.5.1. SPAIN CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.6. NORDIC COUNTRIES
6.2.4.6.1. NORDIC COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.2.4.7. REST OF EUROPE
6.2.4.7.1. REST OF EUROPE CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3. ASIA-PACIFIC
6.3.1. MARKET BY CELLULITE TYPE
6.3.2. MARKET BY PROCEDURE TYPE
6.3.3. MARKET BY END-USER
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.1.1. CHINA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.2. JAPAN
6.3.4.2.1. JAPAN CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.3. INDIA
6.3.4.3.1. INDIA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.4. SOUTH KOREA
6.3.4.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.5. ASEAN COUNTRIES
6.3.4.5.1. ASEAN COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.6. AUSTRALIA & NEW ZEALAND
6.3.4.6.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.3.4.7. REST OF ASIA-PACIFIC
6.3.4.7.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.4. LATIN AMERICA
6.4.1. MARKET BY CELLULITE TYPE
6.4.2. MARKET BY PROCEDURE TYPE
6.4.3. MARKET BY END-USER
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.1.1. BRAZIL CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.4.4.2. MEXICO
6.4.4.2.1. MEXICO CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.4.4.3. REST OF LATIN AMERICA
6.4.4.3.1. REST OF LATIN AMERICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET BY CELLULITE TYPE
6.5.2. MARKET BY PROCEDURE TYPE
6.5.3. MARKET BY END-USER
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.1.1. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.4.2. TURKEY
6.5.4.2.1. TURKEY CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.4.3. SAUDI ARABIA
6.5.4.3.1. SAUDI ARABIA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.4.4. SOUTH AFRICA
6.5.4.4.1. SOUTH AFRICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.5.4.5. REST OF MIDDLE EAST & AFRICA
6.5.4.5.1. REST OF MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE LANDSCAPE
7.1. JOHNSON & JOHNSON
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY STRENGTHS
7.1.4. KEY CHALLENGES
7.2. ABBVIE INC
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY STRENGTHS
7.2.4. KEY CHALLENGES
7.3. BAUSCH HEALTH COMPANIES INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY STRENGTHS
7.3.4. KEY CHALLENGES
7.4. CUTERA INC
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY STRENGTHS
7.4.4. KEY CHALLENGES
7.5. INCELER MEDIKAL
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY STRENGTHS
7.5.4. KEY CHALLENGES
7.6. ZIMMER MEDIZINSYSTEME GMBH
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY STRENGTHS
7.6.4. KEY CHALLENGES
7.7. GALDERMA SA
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY STRENGTHS
7.7.4. KEY CHALLENGES
7.8. SIENTRA INC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY STRENGTHS
7.8.4. KEY CHALLENGES
7.9. ENDO INTERNATIONAL PLC
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY STRENGTHS
7.9.4. KEY CHALLENGES
7.10. CANDELA MEDICAL CORPORATION
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY STRENGTHS
7.10.4. KEY CHALLENGES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF THE PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS

TABLE LIST
TABLE 1: GLOBAL CELLULITE TREATMENT MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: GLOBAL CELLULITE TREATMENT MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 12: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 13: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 15: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 16: EUROPE CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 17: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 18: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 23: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 24: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 25: LATIN AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 26: LATIN AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 27: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 28: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 30: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)

FIGURE LIST
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: GLOBAL CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: GLOBAL CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: GLOBAL CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: GLOBAL CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: GLOBAL CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: GLOBAL CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: GLOBAL CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: GLOBAL CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: GLOBAL CELLULITE TREATMENT MARKET, REGIONAL OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED STATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: CANADA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: UNITED KINGDOM CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: GERMANY CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: FRANCE CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: ITALY CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 22: SPAIN CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 23: NORDIC COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 24: REST OF EUROPE CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 25: CHINA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 26: JAPAN CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 27: INDIA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 28: SOUTH KOREA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 29: ASEAN COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 30: AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 31: REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 32: BRAZIL CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 33: MEXICO CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 34: REST OF LATIN AMERICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 35: UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 36: TURKEY CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 37: SAUDI ARABIA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 38: SOUTH AFRICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 39: REST OF MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

ページTOPに戻る

図表リスト

TABLE LIST
TABLE 1: GLOBAL CELLULITE TREATMENT MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: GLOBAL CELLULITE TREATMENT MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 12: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 13: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 15: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 16: EUROPE CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 17: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 18: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 23: LATIN AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 24: LATIN AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 25: LATIN AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 26: LATIN AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 27: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 28: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 30: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

MARKET OUTLOOK
Triton’s research report predicts that the global cellulite treatment market will experience growth at a CAGR of 9.48% during the forecast period 2023-2030.
The rise in beauty consciousness among consumers has led to a significant increase in demand for aesthetic procedures. The demand for minimally invasive procedures has surged due to their ability to reduce scarring, offer shorter recovery periods, and have fewer complications compared to invasive procedures. As awareness grows regarding the benefits of non-invasive and minimally invasive cosmetic procedures, the cellulite treatment market is projected to expand.
With frequent technological advancements and evolving customer demands, product launches become necessary for progress and innovation. However, while these innovations are necessary, they can often lead to higher prices for the end consumer, which can, in turn, hinder the market’s growth.

REGIONAL OUTLOOK
The cellulite treatment market on a global scale covers a vast range of regions, including Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa.
The Asia-Pacific region is projected to experience the fastest growth globally over the forecast period. This growth can be attributed to the abundance of skilled professionals and high-quality healthcare facilities in the region. Additionally, the region’s medical tourism industry has flourished due to the availability of premium healthcare services and the lower cost of treatments, which adds to the cellulite treatment market’s overall development.

COMPETITIVE OUTLOOK
The prominent firms in the cellulite treatment market include Candela Medical Corporation, Galderma SA, AbbVie Inc, Endo International Plc, Inceler Medikal, Johnson & Johnson, Bausch Health Companies Inc, Sientra Inc, Cutera Inc, and Zimmer MedizinSysteme GmbH.

Bausch Health Companies Inc specializes in developing, manufacturing, and marketing a diverse range of products, with a primary focus on neurology, dermatology, gastroenterology, and international pharmaceuticals. The company’s headquarters is based in Canada, with operations across North America, the Middle East and Africa, Europe, Asia-Pacific, and Latin America. One of its products is Vaserlipo, which utilizes ultrasound energy to provide minimally invasive body contouring solutions.

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Triton Market Research社の分野での最新刊レポート

最新刊レポートはありません。

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Triton Market Research社はどのような調査会社ですか?

Triton Market Researchはヘルスケア、オートメーション、ICT技術、農産業、建設など幅広い産業を対象にした調査およびレポート出版を行っています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

セルライト治療世界市場 2023-2030

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

Triton Market Research社の分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Triton Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?